ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,823Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 392

$528K Total Retail Price of All Prescriptions

Rank: 14 out of 392

413 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
52% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Hampshire
Lower avg

Schedule Two
Controlled Substances

20% of this provider’s 413 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

13% of this provider’s 413 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

2% of this provider’s 6,358 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Hampshire
OXYCODONE HCL 319 22 S2 1 16
SIMVASTATIN 313 271 2 2
HYDROCHLOROTHIAZIDE 284 264 3 7
OMEPRAZOLE 227 200 4 4
HYDROCODONE-ACETAMINOPHEN 215 131 S3 5 14
CITALOPRAM HBR 192 125 6 15
METOPROLOL TARTRATE 190 155 7 8
ATORVASTATIN CALCIUM 170 158 8 10
LISINOPRIL 161 130 9 1
FUROSEMIDE 154 113 10 6
PREDNISONE 139 100 11 39
WARFARIN SODIUM 137 114 12 12
ALLOPURINOL 133 107 13 38
ZOLPIDEM TARTRATE 123 117 14 21
POTASSIUM CHLORIDE 121 109 15 30
METFORMIN HCL 121 73 15 9
ATENOLOL 119 110 17 11
POLYETHYLENE GLYCOL 3350 111 98 18 48
MORPHINE SULFATE ER 110 14 S2 19 71
LOSARTAN POTASSIUM 106 94 20 20
OXYCODONE-ACETAMINOPHEN 105 43 S2 21 33
MORPHINE SULFATE 103 15 S2 22 122
AMLODIPINE BESYLATE 102 82 23 5
PRAVASTATIN SODIUM 100 76 24 17
QUETIAPINE FUMARATE 88 84 25 47
LEVOTHYROXINE SODIUM 88 78 25 3
NITROGLYCERIN PATCH 87 84 27 144
PANTOPRAZOLE SODIUM 83 62 28 24
SERTRALINE HCL 80 52 29 19
AMITRIPTYLINE HCL 79 52 R 30 51
CELEBREX 74 74 31 80
GABAPENTIN 72 49 32 18
METOPROLOL SUCCINATE 71 60 33 13
TAMSULOSIN HCL 70 54 34 37
BISOPROLOL-HYDROCHLOROTHIAZIDE 68 59 35 119
FLUOXETINE HCL 68 53 35 44
LIPITOR 66 57 37 102
CRESTOR 66 46 37 27
IBUPROFEN 63 46 39 64
ADVAIR DISKUS 62 40 40 32
VERAPAMIL ER 61 44 41 132
RANITIDINE HCL 59 41 42 31
NEXIUM 58 39 43 28
LOVASTATIN 58 52 43 23
TRIAMTERENE-HCTZ 56 51 45 112
AZITHROMYCIN 55 48 46 74
CLONIDINE HCL 51 45 47 117
ALENDRONATE SODIUM 50 50 48 42
SUCRALFATE 50 33 48 189
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.